1. Fludarabine-Based Conditioning Secures Engraftment of Second Hematopoietic Stem Cell Allografts (HSCT) in the Treatment of Initial Graft Failure 
Joseph H. Chewning, Hugo Castro-Malaspina, Ann Jakubowski, Nancy A. Kernan, Esperanza B. Papadopoulos, Trudy N. Small, Glenn Heller, Katharine C. Hsu, Miguel A. Perales, Marcel R.M. van den Brink, James W. Young, Susan E. Prockop, Nancy H. Collins, Richard J. O’Reilly, Farid Boulad 
Biology of Blood and Marrow Transplantation 
Volume 13, Issue 11, Pages (November 2007)
DOI: /j.bbmt
Copyright © 2007 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Schema for the most frequently administered cytoreduction regimen. Chemotherapeutic agents and ATG are displayed as a box and shown above the corresponding days these agents were administered. FLU indicates fludarabine and CY indicates cyclophosphamide. The HSCT-2 box indicates the administration of the second stem cell graft and is shown above the day of transplant (day 0).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2007 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Kaplan-Meier probability of overall (A) and disease-free (B) survival by age following second HSCT.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2007 American Society for Blood and Marrow Transplantation Terms and Conditions